Shunsei Hirohata, MD

Nobuhara Clinic
Tokyo, Japan

Involved in clinical research in neuropsychiatric SLE as well as in Behcet's disease, especially neuro-Behcet's disease.

Presentation(s):

• 2541: Development of Severity Classification Criteria for Introduction of Infliximab for Chronic Pogressive Neuro-Behçet's Disease

  Tuesday, October 28, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose